I-131 treatment response in differentiated thyroid neoplasms andevaluation on radiation dose complications. A review of 10 years ofexperience

摘要

Thyroid cancer is the most frequent endocrine malignancy, but its management is stillrncontroversial. It has an interdisciplinary management from different specialities that includes surgery,rnradioiodine (RAI) therapy, and sometimes external radiation therapy. The aim of our work was tornevaluate retrospectively the role of the RAI treatment in well differentiated thyroid carcinomarn(WDTC), in terms of survival and the presence of radiation complications. Methods: we reviewed 94rnmedical records of patients with confirmed WDTC from 1990 to 2004. All of them received RAI postrnsurgery, and the follow up includes blood count, thorax X ray, whole body I-131 scans, andrnthyroglobulin.